Vibroacoustic pulmonary therapy in patients with COVID19 is believed to have a positive effect on oxygen status and a decrease in the duration of respiratory failure
This study aims to recruit the required number of patients for statistical identification of
the effectiveness of vibroacoustic therapy in patients with COVID 19. Obligatory performance
criteria will be presented by the duration of the course of respiratory failure and the
duration of mechanical ventilation in the main and control groups. Optional performance
criteria will be represented by oximetry values and standardization of laboratory parameters
Device: VibroLUNG
Lungs intensive therapy
Other Name: Vibroacustic device
Inclusion Criteria:
1. adults
2. P/F less 300 torr
3. ARDS by Berlin convention
4. COVID 19 bilateral pneumonia
Exclusion Criteria:
1. children
2. acute brain stroke
3. acute coronary syndrome
4. pulmonary embolism
5. implanted pacemaker
Mukatova Irina
Astana, Nur-Sultan, Kazakhstan
Center of pulmonology Astana
Astana, Kazakhstan
Irina Mukatova, PhD
8701 535 96 79
mukatovair@mail.ru